NEW YORK: Celebrating the innovative and impactful use of conversational AI technology across industries, TMCnet awarded Swoop a 2024 Conversational AI Excellence Award. The award recognizes tools, platforms and applications that demonstrate excellence in conversational AI to enhance customer experiences, streamline operations, and drive business success.

“Congratulations to Swoop for receiving a 2024 Conversational AI Excellence Award. Swoop has been selected for demonstrating verifiable excellence in providing conversational AI solutions, tools and applications to enhance customer experiences, streamline operations, and drive business success,” said Rich Tehrani, CEO, TMC. “We’re pleased to recognize this achievement and know we will continue to see great innovation from Swoop in 2024 and beyond.”

In today’s healthcare ecosystem, patients and healthcare providers need on-demand access to reliable information with intuitive, conversational experiences. Generative AI solutions are too risky for the highly technical and regulated pharmaceutical industry, as they could potentially generate non-validated responses (hallucinations) that result in serious health consequences.

To be useful to both users and the pharmaceutical industry, conversational AI agents must provide medically accurate answers that are compliant with regulatory and legal guidelines. Swoop Agents connect patients and providers with valuable, accurate medical information in their moment of need, leading to clinical decisions that improve patients’ lives with answers approved through the medical, legal and regulatory (MLR) review process.

Swoop Agents also put previously inaccessible intelligence into the hands of marketers and brand leaders. Brands can leverage these first-party data and analytics to improve go-to-market strategies, uncover customer knowledge gaps, and optimize brand messaging across all channels. Not only can brands refine marketing programs to meet patient and provider needs with the privacy-safe data generated by Swoop Agents but also they can also reduce spend on primary market research and syndicated data.

“We believe that harnessing the power of first-party data and AI responsibly is essential for unifying and coordinating HCP and patient communications and targeting strategies, to ultimately optimizing health outcomes,” said Scott Rines, President, Swoop. “This award recognizes the importance of creating privacy-safe conversational AI agents that provide accurate information and actionable data to optimize omnichannel strategies.”

Swoop has developed privacy-safe conversational AI agents for more than 100 brands within 15 therapeutic areas including diabetes, cardiovascular, infectious disease, women’s health, oncology, neurology, and rare disease, since 2016.

About Swoop

Swoop is a leading provider of precision AI-driven healthcare omnichannel solutions dedicated to protecting consumer privacy. By prioritizing privacy and compliance, Swoop ensures the highest standards of data protection for its clients and partners. Our superior audience quality segments and 100% MLR-approved conversational AI agents generate meaningful patient and provider engagement, optimal conversion, and increased Rx lift.

About CUSTOMER

Since 1982, CUSTOMER magazine (formerly Customer Interaction Solutions) has been the voice of the customer experience, call/contact center, CRM and teleservices industries. CUSTOMER has helped the industry germinate, grow, mature and prosper, and has served as the leading publication in helping these industries that have had such a positive impact on the world economy to continue to thrive. Through a combination of outstanding and cutting-edge original editorial, industry voices, in-depth lab reviews and the recognition of the innovative leaders in management and technology through our highly valued awards, CUSTOMER strives to continue to be the publication that holds the quality bar high for the industry. Please visit http://www.customer.tmcnet.com.

Fonte: Business Wire